Ocular drug delivery systems play a critical role in the treatment of various eye diseases via
ensuring targeted and efficient delivery of therapeutic agent. The complex anatomy and …

Introduction: Drug delivery to the back of the eye requires strategic approaches that
guarantee the long-term therapeutic effect with patient compliance. Current treatments for …

Numerous novel nano-based ocular drug delivery systems have been developed to
overcome the limitations of conventional drug delivery systems, which have demonstrated …

Ocular drug delivery offers unique challenges and opportunities in the era of novel
therapeutic agents ranging from small molecules to gene therapies. Noninvasive delivery of …

Ocular drug delivery has seen several advances in the past few decades, with respect to
new drugs, improved formulations, targeted delivery, as well as exploration of new routes of …

Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

Controlled and sustained delivery of drugs for ophthalmic diseases continues to remain a
major challenge in the field of pharmaceutical drug delivery. To overcome the problems of …

Drug delivery to the eye is made difficult by multiple barriers (such as the tear film, cornea,
and vitreous) between the surface of the eye and the treatment site. These barriers are …

Topical and systemic administration of drugs to the eye is highly inefficient and there is a
need for controlled, sustained release, particularly for conditions that affect the posterior …

The applications for ocular implants are as broad as the pathology of eye. The success of
treating ophthalmologic disease will be enhanced by targeted and sustained drug delivery …